TR199903295T2 - Sertralinin ertelemeli salgilanan dozaj biçimleri. - Google Patents

Sertralinin ertelemeli salgilanan dozaj biçimleri.

Info

Publication number
TR199903295T2
TR199903295T2 TR1999/03295T TR9903295T TR199903295T2 TR 199903295 T2 TR199903295 T2 TR 199903295T2 TR 1999/03295 T TR1999/03295 T TR 1999/03295T TR 9903295 T TR9903295 T TR 9903295T TR 199903295 T2 TR199903295 T2 TR 199903295T2
Authority
TR
Turkey
Prior art keywords
dosage forms
delayed
sertraline
release dosage
gastroentestinal
Prior art date
Application number
TR1999/03295T
Other languages
English (en)
Inventor
John Curatolo William
Lewis Friedman Hylar
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199903295(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR199903295T2 publication Critical patent/TR199903295T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus, sertralinin Tmax'i ve yan etkileri azaltan ertelemeli salgilanan dozaj biçimleri ile ilgilidir. Genelde dozaj biçimleri gastroentestinal sistem boyuncaki durumlarina duyarli bir sekilde alansal olarak ertelenir ya da gastroentestinal sistem boyuncaki durumlarindan bagimsiz bir biçimde daha önceden belirlenmis bir zaman araligi için geçici olarak ertelenir. Bu tür dozaj biçimlerini tanimlamak için in vitro testler sunulmustur.
TR1999/03295T 1997-07-01 1998-06-16 Sertralinin ertelemeli salgilanan dozaj biçimleri. TR199903295T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
TR199903295T2 true TR199903295T2 (tr) 2000-08-21

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03295T TR199903295T2 (tr) 1997-07-01 1998-06-16 Sertralinin ertelemeli salgilanan dozaj biçimleri.

Country Status (40)

Country Link
EP (1) EP1007024B1 (tr)
JP (1) JP3786715B2 (tr)
KR (1) KR100369698B1 (tr)
CN (4) CN1475208A (tr)
AP (1) AP1199A (tr)
AR (1) AR038394A2 (tr)
AT (1) ATE245415T1 (tr)
AU (1) AU727152B2 (tr)
BG (1) BG64742B1 (tr)
BR (1) BR9809895A (tr)
CA (1) CA2290969C (tr)
DE (1) DE69816624T2 (tr)
DK (1) DK1007024T3 (tr)
DZ (1) DZ2547A1 (tr)
EA (1) EA001906B1 (tr)
ES (1) ES2202858T3 (tr)
GT (1) GT199800091A (tr)
HN (1) HN1998000099A (tr)
HR (1) HRP980376B1 (tr)
HU (1) HUP0301787A3 (tr)
ID (1) ID23187A (tr)
IL (2) IL133081A (tr)
IS (1) IS5267A (tr)
MA (1) MA24585A1 (tr)
NO (1) NO996519L (tr)
NZ (1) NZ501249A (tr)
OA (1) OA11247A (tr)
PA (1) PA8454201A1 (tr)
PE (1) PE84399A1 (tr)
PL (1) PL337799A1 (tr)
PT (1) PT1007024E (tr)
SI (1) SI1007024T1 (tr)
SK (1) SK173299A3 (tr)
TN (1) TNSN98122A1 (tr)
TR (1) TR199903295T2 (tr)
TW (1) TW575437B (tr)
UA (1) UA63953C2 (tr)
UY (1) UY25068A1 (tr)
WO (1) WO1999001122A1 (tr)
ZA (1) ZA985710B (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
ES2290027T3 (es) * 1999-05-20 2008-02-16 Elan Corporation, Plc Formulaciones multiparticuladas y de liberacion controlada de inhibidores selectivos de la recaptacion de serotonina.
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
EP1671628B1 (en) 1999-09-03 2012-10-03 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
EP1272165B1 (en) * 2000-02-10 2010-12-01 BPSI Holdings, Inc. Acrylic enteric coating compositions
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
US20040156900A1 (en) * 2001-04-10 2004-08-12 Shanghvi Dilip Shantilal Time pulsed release composition
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
DE69816624D1 (de) 2003-08-28
PL337799A1 (en) 2000-09-11
SI1007024T1 (en) 2003-12-31
CN1151783C (zh) 2004-06-02
JP3786715B2 (ja) 2006-06-14
ZA985710B (en) 2000-01-10
PA8454201A1 (es) 2000-09-29
EP1007024B1 (en) 2003-07-23
AP9801278A0 (en) 1998-06-30
CN1261273A (zh) 2000-07-26
PE84399A1 (es) 1999-09-11
EP1007024A1 (en) 2000-06-14
TW575437B (en) 2004-02-11
CN1475208A (zh) 2004-02-18
BG64742B1 (bg) 2006-02-28
ID23187A (id) 2000-03-23
IL133081A (en) 2005-09-25
KR20010013522A (ko) 2001-02-26
UY25068A1 (es) 2000-12-29
MA24585A1 (fr) 1998-12-31
GT199800091A (es) 1999-12-21
TNSN98122A1 (fr) 2005-03-15
IL152304A0 (en) 2003-05-29
BR9809895A (pt) 2000-08-01
ES2202858T3 (es) 2004-04-01
NO996519D0 (no) 1999-12-28
CA2290969C (en) 2004-02-17
WO1999001122A1 (en) 1999-01-14
DZ2547A1 (fr) 2003-02-08
BG103916A (en) 2000-07-31
NZ501249A (en) 2001-06-29
KR100369698B1 (ko) 2003-01-30
DE69816624T2 (de) 2004-02-19
UA63953C2 (uk) 2004-02-16
OA11247A (en) 2002-11-19
EA001906B1 (ru) 2001-10-22
CN1494899A (zh) 2004-05-12
NO996519L (no) 2000-02-29
JP2000513751A (ja) 2000-10-17
EA199900965A1 (ru) 2000-08-28
CA2290969A1 (en) 1999-01-14
AR038394A2 (es) 2005-01-12
AP1199A (en) 2003-08-28
HRP980376A2 (en) 1999-04-30
AU727152B2 (en) 2000-12-07
HN1998000099A (es) 1998-10-22
ATE245415T1 (de) 2003-08-15
DK1007024T3 (da) 2003-11-17
CN1475209A (zh) 2004-02-18
IS5267A (is) 1999-11-23
SK173299A3 (en) 2000-11-07
HK1027982A1 (en) 2001-02-02
HRP980376B1 (en) 2002-12-31
HUP0301787A3 (en) 2005-04-28
IL133081A0 (en) 2001-03-19
PT1007024E (pt) 2003-11-28
HUP0301787A2 (hu) 2003-11-28
AU7545198A (en) 1999-01-25

Similar Documents

Publication Publication Date Title
DE69835251D1 (de) TMR Stent und zugehöriges Einführsystem
DE69812266D1 (de) Modulares Befestigungssystem für Hüte, Abzeichen u. dgl
DE69711045D1 (de) Vitamin c abgabesystem
DE69842026D1 (de) Dynamisches instandhaltung verwaltungssystem
DE69730666D1 (de) Stentanbringungssystem
DE69731915D1 (de) Stentanbringungssystem
DE59703540D1 (de) Gurtsystem für Gefechtszwecke
TR200101333T2 (tr) Bir ensülin sensitizörü ve başka bir anti-diyabetik maddenin değiştirilmiş salımı için farmasötik terkip.
MX9205998A (es) Sistema automatico para la distribucion de llamadas telefonicas.
DE69840025D1 (de) Assoziierter antworten
DE69800558D1 (de) Anrufweiterleitungssystem
ATE123930T1 (de) Darreichungsform für mikrobläschen- echokontrastmittel.
ATE301100T1 (de) Verteiltes abgabesystem für konzentrierte chemiekalien
DK0968106T3 (da) Belastningsfordelende garner og selebånd
FI961437A7 (fi) Vaikuttavan aineen luovuttava systeemi
DK0852587T3 (da) Syntetiske peptider der inhiberer IL-6-aktivitet
CA2290969A1 (en) Delayed-release dosage forms of sertraline
IT1270618B (it) Proteine ad attivita' antitumorale
ATE305517T1 (de) Neurotrypsin
ITRM920138A0 (it) Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono.
ATE124271T1 (de) Selbstklebendes matrixsystem für transdermal gesteuerte abgabe von piribedil.
DE69427251D1 (de) Verabreichungssystem für Arzneistoffe
ATE57526T1 (de) P-acylaminobenzamide.
DE59505895D1 (de) Verteiler-bzw. Zustellerwagen
RU1826866C (ru) Ретрактор